|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-4-27
|
|
pubmed:abstractText |
Coronary artery disease (CAD) is the leading cause of mortality after the first year of heart transplantation. End-stage renal failure (ESRF) is more frequent because of long-term survival. Impact of ESRF on cardiac mortality in heart transplant patients is unappreciated. The hypothesis of accelerated CAD in uremic patients has been suggested.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0902-0063
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15108764-Adult,
pubmed-meshheading:15108764-Case-Control Studies,
pubmed-meshheading:15108764-Coronary Disease,
pubmed-meshheading:15108764-Cyclosporine,
pubmed-meshheading:15108764-Female,
pubmed-meshheading:15108764-Heart Transplantation,
pubmed-meshheading:15108764-Humans,
pubmed-meshheading:15108764-Immunosuppressive Agents,
pubmed-meshheading:15108764-Incidence,
pubmed-meshheading:15108764-Kidney Failure, Chronic,
pubmed-meshheading:15108764-Male,
pubmed-meshheading:15108764-Retrospective Studies,
pubmed-meshheading:15108764-Risk Factors,
pubmed-meshheading:15108764-Survival Rate,
pubmed-meshheading:15108764-Triglycerides
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
End-stage renal failure and cardiac mortality after heart transplantation.
|
|
pubmed:affiliation |
Service de Chirurgie Cardio-vasculaire et Thoracique, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
|
|
pubmed:publicationType |
Journal Article
|
